<DOC>
	<DOCNO>NCT00234702</DOCNO>
	<brief_summary>Chronic kidney disease ( CKD ) result loss ability filter excrete phosphate . The body 's attempt adjust increase level phosphate blood result elevate level hormone mineral result serious clinical consequence . This study conduct evaluate safety efficacy lanthanum carbonate lower high level phosphorus blood subject CKD Stages 3 4 compare placebo .</brief_summary>
	<brief_title>Efficacy Safety Lanthanum Carbonate Reducing Serum Phosphorus Levels Subjects With Stage 3 4 Chronic Kidney Disease</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>Under physician 's care CKD &gt; 2 month expect begin dialysis 4 month Screening estimate GFR 1559 mL/1.73 m2 Serum phosphorus &gt; = 4.7 mg/d follow washout Requiring treatment cinacalcet HCI compound contain phosphate , aluminum , calcium magnesium Rapidly progress glomerulonephritis Cirrhosis clinically significant liver disease Past present uncontrolled peptic ulcer , Crohn 's disease , malignancy recent GI bleed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
</DOC>